secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autonomix Medical, Inc. (AMIX)
CIK:        0001617867
Form:       8-K
Filed at:   2026-01-16T23:59:59+00:00
Accession:  0001437749-26-001381
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Autonomix Medical receives Nasdaq bid price deficiency notice; 180-day cure period
--------------------------------------------------------------------------------

- Received Nasdaq letter on Jan 14, 2026: bid price below $1.00 for 30 consecutive business days.
- Initial 180-day compliance period ends July 13, 2026; need $1.00 close for 10 consecutive days.
- If non-compliant by July 13, may get second 180-day period if meets other listing standards.
- Company may consider a reverse stock split to regain compliance with Bid Price Rule.
- No guarantee of regaining compliance; delisting possible if not cured or appeal fails.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617867/000143774926001381/0001437749-26-001381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617867/000143774926001381/amix20260114_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-001381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer